Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
McMaster University
$105,000.00
Exploring the Antiviral Mechanism of NK cells against HSV-2
EF 2012-13
Résumé
Herpes simplex virus type 2 (HSV-2) is one of the most prevalent sexually transmitted infections across the globe. As the main cause of genital herpes, it presents a large burden on the health care system. Furthermore, it has been implicated in the infection, transmission, and disease progression of human immunodeficiency virus (HIV), a deadly chronic viral infection with no known cure. Therefore, it is imperative to develop an effective vaccine and treatment strategy against HSV-2. We are investigating a specific immune response responsible for controlling early HSV-2 infection. Natural killer (NK) cells are immune cells that respond rapidly to HSV-2 infection and are a key element in controlling the early stages of infection. The methods of activating these NK cells against HSV-2 and how they control infection are not fully known. Interleukin-15 and type I interferon are immune components produced by our bodies that initiate an immune response against viral infection. In the case of HSV-2, these components appear to be necessary for the activation and function of NK cells against HSV-2 infection. Once the NK cells are activated, there is evidence suggesting that they can then increase the production of nitric oxide (a multi-functional molecule that is produced by the body; NO) at the site of infection. Increased production of NO may prevent the virus from reproducing, which can limit the symptoms and spread of HSV-2. In determining the existence of this specific immune response, we can develop therapies based on enhancing this process to control or prevent HSV-2 infection. If we can minimize the symptoms and spread of HSV-2, we will be able to improve the quality of life of those living with genital herpes, thereby lowering the HSV-2 related burden on the healthcare system. Furthermore, a treatment for HSV-2 could lower the rate of HIV transmission and improve the outcome for those who are currently infected with HIV.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
283843
Name
Lee Amanda J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Exploring the Antiviral Mechanism of NK cells against HSV-2
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Animal Handling; Elisa; Flow Cytometry; Herpes Simplex Virus Type 2; Interferons; Interleukin-15; Natural Killer Cells; Nitric Oxide; Viral Titering
Abstract
Herpes simplex virus type 2 (HSV-2) is one of the most prevalent sexually transmitted infections across the globe. As the main cause of genital herpes, it presents a large burden on the health care system. Furthermore, it has been implicated in the infection, transmission, and disease progression of human immunodeficiency virus (HIV), a deadly chronic viral infection with no known cure. Therefore, it is imperative to develop an effective vaccine and treatment strategy against HSV-2. We are investigating a specific immune response responsible for controlling early HSV-2 infection. Natural killer (NK) cells are immune cells that respond rapidly to HSV-2 infection and are a key element in controlling the early stages of infection. The methods of activating these NK cells against HSV-2 and how they control infection are not fully known. Interleukin-15 and type I interferon are immune components produced by our bodies that initiate an immune response against viral infection. In the case of HSV-2, these components appear to be necessary for the activation and function of NK cells against HSV-2 infection. Once the NK cells are activated, there is evidence suggesting that they can then increase the production of nitric oxide (a multi-functional molecule that is produced by the body; NO) at the site of infection. Increased production of NO may prevent the virus from reproducing, which can limit the symptoms and spread of HSV-2. In determining the existence of this specific immune response, we can develop therapies based on enhancing this process to control or prevent HSV-2 infection. If we can minimize the symptoms and spread of HSV-2, we will be able to improve the quality of life of those living with genital herpes, thereby lowering the HSV-2 related burden on the healthcare system. Furthermore, a treatment for HSV-2 could lower the rate of HIV transmission and improve the outcome for those who are currently infected with HIV.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lee, Amanda J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~